Encainide for refractory ventricular tachyarrhythmia
- 31 August 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 52 (5), 495-500
- https://doi.org/10.1016/0002-9149(83)90014-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Use of nonsustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmiaAmerican Heart Journal, 1983
- Antiarrhythmic efficacy of encainide in patients with refractory recurrent ventricular tachycardia.Circulation, 1981
- Total Suppression of Ventricular Arrhythmias by EncainideNew England Journal of Medicine, 1980
- Suddent cardic death— Management of the patient at riskCurrent Problems in Cardiology, 1980
- Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agentThe American Journal of Cardiology, 1979
- Electrophysiologic effects of encainide (MJ 9067) on canine purkinje fibresEuropean Journal of Pharmacology, 1978
- Management of patients with malignant ventricular arrhythmiasThe American Journal of Cardiology, 1977
- Programmed "Trendscription"Published by American Medical Association (AMA) ,1975
- Approaches to Sudden Death from Coronary Heart DiseaseCirculation, 1971
- Myocardial ischemia after maximal exercise in healthy menAmerican Heart Journal, 1965